Inside Precision Medicine July 19, 2024
IPM Staff

In 2020, non-Hispanic Whites made up 57.8 percent of the population, according to the U.S. Census Bureau. In 2021, researchers estimated the proportion of samples from individuals of European ancestry they included in genome-wide association studies (GWAS) to be 86.3 percent. Researchers have now published the results of a GWAS using samples from the United States Department of Veterans Affairs (VA) Million Veteran Program (MVP) that includes more than 635,000 samples—29 percent of them from individuals of color, i.e. those who do not self-identify as non-Hispanic White.

“Diversity is critical in advancing genomic studies, providing foundational data for downstream implementation ranging from risk prediction to targeted therapeutics,” wrote a group of 66 authors in the paper appearing in the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Pharma / Biotech, Precision Medicine
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Oncologist talks personalized medicine for pancreatic cancer
AI offers a step above genomic solutions
How Mayo Clinic is using real-world data to advance precision medicine
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Share This Article